✦ LIBER ✦
Alemtuzumab in Combination With Methylprednisolone Is a Highly Effective Induction Regimen for Patients With Chronic Lymphocytic Leukemia and Deletion of TP53: Final Results of the National Cancer Research Institute CLL206 Trial
✍ Scribed by Pettitt, A. R.; Jackson, R.; Carruthers, S.; Dodd, J.; Dodd, S.; Oates, M.; Johnson, G. G.; Schuh, A.; Matutes, E.; Dearden, C. E.
- Book ID
- 111952282
- Publisher
- American Society of Clinical Oncology
- Year
- 2012
- Tongue
- English
- Weight
- 246 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0732-183X
No coin nor oath required. For personal study only.